ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Recommendations for RhD testing and administration of anti-D immune globulin for patients undergoing pregnancy termination[1-5]

Recommendations for RhD testing and administration of anti-D immune globulin for patients undergoing pregnancy termination[1-5]
Organization (year) Gestational age to initiate Rh testing and administer anti-D immune globulin in D-negative patients Notes
SFP (2022) ≥12 weeks
  • Shared decision making should be used, and some patients may request testing/administration at earlier gestational ages or decline testing/administration altogether.
  • When anti-D immune globulin is given, the following doses are recommended:
    • ≤12 weeks (ie, patient preference, sharp curettage*): 50 mcg
    • 13 to 18 weeks: 100 mcg
    • ≥19 weeks: 300 mcg
NAF (2022) ≥12 weeks  
WHO (2022) ≥12 weeks  
ACOG (2020) All gestations
  • Shared decision making should be used when testing/administration are not available or would delay the procedure.
  • When anti-D immune globulin is given, the following doses are typically given:
    • <12 weeks: 50 mcg
    • ≥12 weeks: 300 mcg

SFP: Society of Family Planning; NAF: National Abortion Federation; WHO: World Health Organization; ACOG: American College of Obstetricians and Gynecologists.

* Uterine aspiration rather than sharp curettage is the standard surgical method of termination of pregnancy; it is unclear how sharp curettage impacts the need for anti-D immune globulin.
References:
  1. Horvath S, Goyal V, Traxler S, Prager S. Society of Family Planning committee consensus on Rh testing in early pregnancy. Contraception 2022; 114:1.
  2. 2022 Clinical Policy Guidelines for Abortion Care. National Abortion Federation. Available at: https://prochoice.org/providers/quality-standards/ (Accessed on November 3, 2022).
  3. Abortion Care Guideline (2022). World Health Organization. Available at: https://www.who.int/publications/i/item/9789240039483 (Accessed on November 3, 2022).
  4. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225. Obstet Gynecol 2020; 136:855.
  5. Prevention of Rh D Alloimmunization: ACOG Practice Bulletin Summary, Number 181. Obstet Gynecol 2017; 130:481.
Graphic 140124 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟